ESI Blocks New Teva Migraine Drug

Discussion in 'Teva Neuroscience' started by anonymous, Oct 18, 2018 at 4:01 PM.

Tags: Add Tags
  1. #1 anonymous, Oct 18, 2018 at 4:01 PM
    anonymous

    anonymous Guest

    We are screwed now!!!
     
    Quote

  2. #2 anonymous, Oct 18, 2018 at 7:32 PM
    anonymous

    anonymous Guest

    Can we do anything right as a company. Let’s hope others don’t follow suit.
     
    Quote
  3. #3 anonymous, Oct 22, 2018 at 4:50 AM
    anonymous

    anonymous Guest

    With the market access gurus in Brenden and George how can we lose? Hahahaha!
     
    Quote
  4. #4 anonymous, Oct 22, 2018 at 10:47 AM
    anonymous

    anonymous Guest

    They are in way over their heads!!! Teva made a bad choice picking them to run this - or I should say now run this into the ground.
     
    Quote
  5. #5 anonymous, Oct 22, 2018 at 10:52 AM
    anonymous

    anonymous Guest

    Yep - it’s like bringing a chicken to a cock fight. Big Pharma has a lot of experience and relationships with these accounts - much more then us!
     
    Quote
  6. #6 anonymous, Oct 29, 2018 at 9:36 AM
    anonymous

    anonymous Guest

    You ARE big pharma. you just suck.
     
    Quote
  7. #7 anonymous, Jan 17, 2019 at 5:43 PM
    anonymous

    anonymous Guest

    whatever
     
    Quote
  8. #8 anonymous, Jan 18, 2019 at 2:14 PM
    anonymous

    anonymous Guest

    thats good news
     
    Quote
  9. #9 anonymous, Jan 19, 2019 at 12:57 PM
    anonymous

    anonymous Guest

    esi will reverse
     
    Quote
  10. #10 anonymous, Apr 16, 2019 at 8:54 AM
    anonymous

    anonymous Guest

    Aimovig and Emgality are both preferred and not blocked.
     
    Quote
Reply to Thread